TFM
RPRX icon

TFC Financial Management’s Royalty Pharma RPRX Stock Holding History

TFC Financial Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$898 Hold
16
– – ﹤0.01% 664
2026
Q1 		$768 Hold
16
– – ﹤0.01% 641
2025
Q4 		$619 Hold
16
– – ﹤0.01% 668
2025
Q3 		$565 Hold
16
– – ﹤0.01% 698
2025
Q2 		$577 Buy
+16
New +$530 ﹤0.01% 655
2024
Q3 		– Sell
-1
Closed -$27 – 1084
2024
Q2 		$27 Sell
1
-28
-97% -$776 ﹤0.01% 947
2024
Q1 		$881 Hold
29
– – ﹤0.01% 567
2023
Q4 		$815 Buy
29
+14
+93% +$385 ﹤0.01% 540
2023
Q3 		$408 Buy
+15
New +$446 ﹤0.01% 630

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TFC Financial Management's RPRX Position: Q2 2026 in Review

TFC Financial Management held its Royalty Pharma (RPRX) position steady in Q2 2026 at 16 shares worth $898. The position accounts for ﹤0.01% of the portfolio, ranked #664.

TFC Financial Management first reported a position in RPRX in Q3 2023 and has held it in 9 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • TFC Financial Management held 16 shares of Royalty Pharma worth $898 as of Q2 2026.
  • TFC Financial Management left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #664 holding.
  • TFC Financial Management first reported a position in Royalty Pharma in Q3 2023 and has held it in 9 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.